Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$34.5 - $42.19 $225,216 - $275,416
-6,528 Reduced 5.35%
115,502 $4.87 Million
Q1 2023

May 15, 2023

SELL
$33.32 - $40.98 $14.4 Million - $17.7 Million
-430,745 Reduced 77.92%
122,030 $4.35 Million
Q4 2022

Feb 14, 2023

BUY
$25.32 - $51.45 $12.9 Million - $26.1 Million
507,684 Added 1125.91%
552,775 $20.3 Million
Q3 2022

Nov 14, 2022

BUY
$46.5 - $79.14 $96,766 - $164,690
2,081 Added 4.84%
45,091 $2.13 Million
Q2 2022

Aug 15, 2022

SELL
$63.06 - $84.75 $343,992 - $462,311
-5,455 Reduced 11.26%
43,010 $3.08 Million
Q1 2022

May 16, 2022

SELL
$74.15 - $99.36 $964,320 - $1.29 Million
-13,005 Reduced 21.16%
48,465 $3.92 Million
Q4 2021

Feb 14, 2022

BUY
$86.01 - $102.89 $586,760 - $701,915
6,822 Added 12.48%
61,470 $6.31 Million
Q3 2021

Nov 15, 2021

BUY
$84.7 - $96.31 $182,274 - $207,259
2,152 Added 4.1%
54,648 $4.78 Million
Q2 2021

Aug 16, 2021

BUY
$76.44 - $89.57 $4.01 Million - $4.7 Million
52,496 New
52,496 $4.7 Million

Others Institutions Holding SYNH

About Syneos Health, Inc.


  • Ticker SYNH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,653,000
  • Description
  • Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, de...
More about SYNH
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.